Clinical Trial Update: Role of Hyaluronic Acid in Causing Cancer Stem Cell Growth in the Bones of Patients With Breast Cancer

View source ↗

Summary

A clinical trial evaluating whether hyaluronic acid promotes cancer stem cell growth in the bones of patients with breast cancer has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer with Bone Metastases

Drugs mentioned

• Hyaluronic acid (hyaluronic acid)

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Breast Carcinoma Metastatic to the Bone, Stage IV Breast Cancer | Status: WITHDRAWN